Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil in Critical Limb Ischemia (ESPECIAL)
NCT00596752Phase 4Completed
- Sponsor
- UCB
- Start
- Mar 2004
- Primary completion
- May 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 6
01
Overview
A Phase 4 trial of Alprostadil Liposomes for Injection in critical limb ischemia (CLI), sponsored by UCB. Started Mar 2004; status: completed.
02
Drugs
Alprostadil Liposomes for Injection
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00596752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596752.